Connor, Clark & Lunn Investment Management (CC&L)’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-59,100
Closed -$428K 1222
2020
Q1
$428K Buy
+59,100
New +$438K ﹤0.01% 729
2017
Q3
Sell
-149,100
Closed -$1.15M 950
2017
Q2
$1.15M Sell
149,100
-2,450
-2% -$20.7K 0.01% 475
2017
Q1
$1.36M Buy
+151,550
New +$1.58M 0.01% 449
2015
Q3
Sell
-41,800
Closed -$382K 800
2015
Q2
$382K Buy
41,800
+13,500
+48% +$102K ﹤0.01% 464
2015
Q1
$191K Buy
+28,300
New +$114K ﹤0.01% 508

Other funds holding NPTN

Connor, Clark & Lunn Investment Management (CC&L)'s NPTN Position: Q2 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of NEOPHOTONICS CORP (NPTN) in Q2 2020, closing a stake of 59,100 shares — an estimated $428K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NPTN in Q1 2015 and held it in 5 quarters. The position peaked at $1.36M in Q1 2017. 163 funds tracked by Wall St. Rank hold NPTN as of Q2 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining NEOPHOTONICS CORP position as of Q2 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 59,100 NEOPHOTONICS CORP shares in Q2 2020, an estimated $428K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 5 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s NEOPHOTONICS CORP position peaked at $1.36M in Q1 2017.
  • 163 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2020, filed 13 Aug 2020.